Ascendis Pharma A/S
NASDAQ:ASND

Watchlist Manager
Ascendis Pharma A/S Logo
Ascendis Pharma A/S
NASDAQ:ASND
Watchlist
Price: 126.04 USD 0.01%
Market Cap: 7.2B USD
Have any thoughts about
Ascendis Pharma A/S?
Write Note

Ascendis Pharma A/S
Current Portion of Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Ascendis Pharma A/S
Current Portion of Long-Term Debt Peer Comparison

Comparables:
GMAB
ZEAL
B
BAVA
F
FLUO
BIOPOR

Competitive Current Portion of Long-Term Debt Analysis
Latest Figures & CAGR of Competitors

Company Current Portion of Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Ascendis Pharma A/S
NASDAQ:ASND
Current Portion of Long-Term Debt
€21.4m
CAGR 3-Years
45%
CAGR 5-Years
35%
CAGR 10-Years
N/A
Genmab A/S
CSE:GMAB
Current Portion of Long-Term Debt
kr94m
CAGR 3-Years
17%
CAGR 5-Years
25%
CAGR 10-Years
N/A
Zealand Pharma A/S
CSE:ZEAL
Current Portion of Long-Term Debt
kr15.9m
CAGR 3-Years
1%
CAGR 5-Years
-25%
CAGR 10-Years
N/A
B
Bavarian Nordic A/S
CSE:BAVA
Current Portion of Long-Term Debt
kr41.9m
CAGR 3-Years
-68%
CAGR 5-Years
21%
CAGR 10-Years
17%
F
Fluoguide AS
STO:FLUO
Current Portion of Long-Term Debt
kr10.2m
CAGR 3-Years
299%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bioporto A/S
CSE:BIOPOR
Current Portion of Long-Term Debt
kr2.2m
CAGR 3-Years
8%
CAGR 5-Years
-5%
CAGR 10-Years
60%

See Also

What is Ascendis Pharma A/S's Current Portion of Long-Term Debt?
Current Portion of Long-Term Debt
21.4m EUR

Based on the financial report for Jun 30, 2024, Ascendis Pharma A/S's Current Portion of Long-Term Debt amounts to 21.4m EUR.

What is Ascendis Pharma A/S's Current Portion of Long-Term Debt growth rate?
Current Portion of Long-Term Debt CAGR 5Y
35%

Over the last year, the Current Portion of Long-Term Debt growth was -20%. The average annual Current Portion of Long-Term Debt growth rates for Ascendis Pharma A/S have been 45% over the past three years , 35% over the past five years .

Back to Top